Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07317011 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

"Referral Attivo" Delta, Dallo Screening Alla Presa in Carico.

Study acronym: HDV-Reflex
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 9, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion pushed from Aug 31, 2026 to Sep 30, 2026
    • Study sites: 3 to 1
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the "Active Delta Referral" Project is to estimate the prevalence of anti-HDV positivity among HBsAg-positive patients hospitalized in the Department of Medicine at ASST Papa Giovanni XXIII in Bergamo, as well as among patients at the SerD and the Prison Healthcare Unit of the same ASST, following the introduction of the new methodology in 2025, and to compare these findings with existing estimates for outpatients.
Trial Details
NCT Number NCT07317011
Lead Sponsor FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Conditions
(from sponsor)		 Hepatitis, Delta
Related terms Hepatitis D
Enrollment 244 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov